SCHEMBL23787459

SCHEMBL23787459

CCOCCOc1ccc2c(=O)c3ccccc3sc2c1OCCOCC

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.40
NPC1 O15118 2/20 0.40
RAB9A P51151 2/20 0.40
HPGD P15428 2/20 0.40
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40
NCF1 P14598 1/20 0.39
ALDH1A1 P00352 5/20 0.39
L3MBTL1 Q9Y468 3/20 0.39
HCRTR1 O43613 2/20 0.39
LMNA P02545 2/20 0.39
POLB P06746 2/20 0.39
KDM4E B2RXH2 6/20 0.37
TDP1 Q9NUW8 1/20 0.37
CSF1R P07333 1/20 0.36
CYP19A1 P11511 1/20 0.36
RXFP1 Q9HBX9 1/20 0.35
HTT P42858 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21635970 0.96 MAPT (0.40) MAPTNPC1RAB9AHPGDCYP1A2
SCHEMBL30173371 0.87 MAPT (0.44) MAPTNPC1RAB9AHPGDCYP1A2
SCHEMBL30173373 0.83 IDO1 (0.43) MAPTNPC1RAB9AHPGDCYP1A2
SCHEMBL23648174 0.83 IDO1 (0.43) MAPTNPC1RAB9AHPGDCYP1A2
SCHEMBL23647933 0.83 MAPT (0.40) MAPTNPC1RAB9AHPGDCYP1A2
SCHEMBL30291035 0.83 MAPT (0.40) MAPTNPC1RAB9AHPGDCYP1A2
SCHEMBL21624276 0.77 F9 (0.43) MAPTNPC1RAB9AHPGDCYP1A2
SCHEMBL30017437 0.77 F9 (0.43) MAPTNPC1RAB9AHPGDCYP1A2
SCHEMBL14021074 0.77 KDM4E (0.51) MAPTNPC1RAB9AALDH1A1L3MBTL1
SCHEMBL30998121 0.75 MAPT (0.43) MAPTNPC1RAB9AHPGDCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210277017-A1 Thioxanthone Derivatives, Composition Comprising the Same and Pattern Forming Method Comprising Said Composition LINTFIELD LIMITED (GB) 2021-09-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210277017-A1 Thioxanthone Derivatives, Composition Comprising the Same and Pattern Forming Method Comprising Said Composition TPMT, TST, PPOX MAPT 410/4885NPC1 2592/4885RAB9A 3603/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.